Real-world efficacy and safety of glecaprevir/pibrentasvir in Japanese adolescents with chronic hepatitis C: a prospective multicenter study

J Gastroenterol　58/P.405-412/2023

Tatsuki Mizuochi• Itaru Iwama• Ayano Inui• Yoshinori Ito•Yugo Takaki• Sotaro Mushiake, Daisuke Tokuhara• Takashi Ishige9•Koichi Ito10• Jun Murakami11• Haruka Hishiki• Hitoshi Mikami•Kazuhiko Bessho• Ken Kato• Ryosuke Yasuda, Yushiro Yamashita,Tanaka Y, Hitoshi Tajiri

Clinical outcomes of antithrombin III-based therapy for patients with portal vein thrombosis: A retrospective, multicenter study

Hepatol Res　53/P.51-60/2023

Korenobu Hayama 1, Masanori Atsukawa 1 2, Akihito Tsubota 3, Chisa Kondo 2, Motoh Iwasa 4, Hiroshi Hasegawa 4, Koichi Takaguchi 5, Akemi Tsutsui 5, Haruki Uojima 6, Hisashi Hidaka 6, Hironao Okubo 7, Tatsuya Suzuki 8, Kentaro Matsuura 9, Toshifumi Tada 10, Naoto Kawabe 11, Joji Tani 12, Asahiro Morishita 12, Toru Ishikawa 13, Yoshitaka Arase 14, Yoshihiro Furuichi 15, Keizo Kato 16, Kazuhito Kawata 17, Makoto Chuma 18, Akito Nozaki 18, Atsushi Hiraoka 19, Tsunamasa Watanabe 8, Tatehiro Kagawa 14, Hidenori Toyoda 20, Nobuhiko Taniai 21, Hiroshi Yoshida 22, Tanaka Y, Katsuhiko Iwakiri 2, Ktk Liver Study Group

Clinical impact of bile-derived exosomal miRNAs as novel diagnostic and prognostic biomarkers for biliary tract cancers.

Cancer Sci　114/P.295-305/2023

Yoshida M, Yukawa H, Hayashi K, Naitoh I,Miyabe K, Hori Y, Natsume M, Jinno N,Kato A,Kachi K,Asano G,Sahashi H ,Toyohar T, aKuno K,Kito Y, Kondo H, Hirano A, Okumura F, Anbe K, Baba Y, Kataoka H, Tanaka Y

Comparison of endoscopic submucosal resection with ligation and endoscopic submucosal dissection for small rectal neuroendocrine tumors: A multicenter retrospective study

DEN Open　3/P.e163-/2023

Matsuno K, Miyamoto H, Kitada H, Yoshimatsu S, Tamura F, Sakurai K, Fukubayashi K, Shono T, Setoyama H, Matsuyama T, Suko S, Narita R, Honda M, Tateyama M, Naoe H, Morinaga J, Tanaka Y, Gushima R

A Randomized Phase 2 Study (JADE) of the HBV Capsid Assembly Modulator JNJ-56136379 With or Without a Nucleos(t)ide Analogue in Patients With Chronic Hepatitis B Infection

Gut　Jan 25:gutjnl-2022-328041. . Online ahead of print./P.-/2023

Harry LA Janssen,1,2 Jinlin Hou,3 Tarik Asselah,4 Henry LY Chan,5 Fabien Zoulim,6 Tanaka Y,7 Ewa Janczewska,8 Ronald G. Nahass,9 Stefan Bourgeois,10 Maria Buti,11 Pietro Lampertico,12,13 Oliver Lenz,14 Thierry Verbinnen,14 Joris Vandenbossche,14 Willem Talloen,14 Ronald Kalmeijer,15 Maria Beumont,15 Michael Biermer,14,* Umesh Shukla15

Pharyngeal endoscopic submucosal dissection for a pyriform sinus lesion extending beyond the arytenoid to the vocal folds

Endoscopy　55/P.E242-E243/2023

Waki K, Matsuno K, Miyamoto H, Gushima R, Takeda H, Orita Y, Tanaka Y

Efficacy of a new traction method using ring‑shaped thread for endoscopic submucosal dissection in the pharynx

Esophagus　20/P.256-263/2023

Matsuno K, Miyamoto H, Takashi Shono T, Waki K, Tateyama M, Naoe H, Miyamaru S, Murakami D, Orita Y, Morinaga J, Tanaka Y, Gushima R

Outcome of nucleos(t)ide analog cessation in patients with treatment for prevention of or against hepatitis B virus reactivation

Hepatol Res　53/P.289-300/2023

Takanori Suzuki 1, Kentaro Matsuura 1, Kenji Urakabe 2, Fumihiro Okumura 2, Hayato Kawamura 3, Satoshi Sobue 3, Sho Matoya 4, Tomokatsu Miyaki 4, Yoshihide Kimura 5, Daisuke Kato 6, Atsunori Kusakabe 6, Yoshito Tanaka 7, Atsushi Ozasa 8, Yoshihito Nagura 1, Kei Fujiwara 1, Shunsuke Nojiri 1, Shinya Hagiwara 9, Shigeru Kusumoto 9, Takako Inoue 10, Yasuhito Tanaka 11, Hiromi Kataoka 1

Risk factors for portopulmonary hypertension in patients with cirrhosis: a prospective, multicenter study

Hepatol Int　17/P.139-149/2023

Masanori Atsukawa1 · Akihito Tsubota2 · Chisa Kondo1 · Kaori‑Shioda Koyano1 · Toru Ishikawa3 · Hidenori Toyoda4 ·Koichi Takaguchi5 · Tsunamasa Watanabe6 · Kentaro Matsuura7 · Chikara Ogawa8 · Atsushi Hiraoka9 ·Hironao Okubo10 · Masakuni Tateyama11 · Haruki Uojima12 · Akito Nozaki13 · Makoto Chuma13 · Keizo Kato14 ·Shigeru Mikami15 · Joji Tani16 · Asahiro Morishita16 · Kazuhito Kawata17 · Toshifumi Tada18 · Yoshihiro Furuichi19 ·Tomomi Okubo20 · Tadamichi Kawano1 · Taeang Arai1 · Naoto Kawabe21 · Naohiro Kawamura22 · Tadashi Ikegami23 ·Makoto Nakamuta24 · Shigefuku R, Iwasa M, Tanaka Y, Hatano M, Iwakiri K

Long-Term Cell Fate and Functional Maintenance of Human Hepatocyte through Stepwise Culture Configuration

FASEB Journal　37/P.e22750-/2023

Go Sugahara1,2, Yuji Ishida1,2, Jae-Jin Lee3, Meng Li4, Yasuhito Tanaka5, Hyungjin Eoh3, Yusuke Higuchi6, and Takeshi Saito1,

A longitudinal study to detect hepatitis B surface and core-related antigens in chronic hepatitis B patients with hepatitis B surface antigen seroclearance using highly sensitive assays

J Clin Virol　160/P.-/2023

Wong D K-H , Inoue T, Mak L-Y 1, Hui R W-H, Fung J, Cheung K-S, Seto W-K, Tanaka Y, Yuen M-F

Hepatitis B core-related antigen: a novel and promising surrogate biomarker to guide anti-HBV therapy.

Clin Mol Hepatol　Online ahead of print./P.-/2023

Inoue T, Watanabe T, Tanaka Y.

Therapeutic Modifications without Discontinuation of Atezolizumab Plus Bevacizumab Therapy Are Associated with Favorable Overall Survival and Time to Progression in Patients with Unresectable Hepatocellular Carcinoma

Cancers (Basel)　15/P.1568-/2023

Takayuki Tokunaga 1, Masakuni Tateyama 1, Yasuteru Kondo 2, Satoshi Miuma 3, Shiho Miyase 4, Kentaro Tanaka 1, Satoshi Narahara 1, Hiroki Inada 1, Sotaro Kurano 1, Yoko Yoshimaru 1, Katsuya Nagaoka 1, Takehisa Watanabe 1, Hiroko Setoyama 1, Kotaro Fukubayashi 5, Motohiko Tanaka 6, Tanaka Y

A novel anti-HBV agent, E-CFCP, restores Hepatitis B virus (HBV)-induced senescence-associated cellular marker perturbation in human hepatocytes.

Virus Res　329/P.199094-/2023

Takamatsu Y, Hayashi S, Kumamoto H, Imoto S, Tanaka Y, Mitsuya H, Higashi-Kuwata N.

Persistent hepatic IFN system activation in HBV-HDV infection determines viral replication dynamics and therapeutic response.

JCI Insight　8/P.e162404-/2023

Chida T, Ishida Y, Morioka S, Sugahara G, Han C, Lam B, Yamasaki C, Sugahara R, Li M, Tanaka Y, Liang TJ, Tateno C, Saito T.

Antiviral therapy substantially reduces hepatocellular carcinoma risk in chronic Hepatitis B patients in the indeterminate phase

Hepatology　Online ahead of print./P.-/2023

Huang DQ, Tran A, Yeh ML, Yasuda S, Tsai PC, Huang CF, Dai CY, Ogawa E, Ishigami M, Ito T, Kozuka R, Enomoto M, Suzuki T, Yoshimaru Y, Preda CM, Marin RI, Sandra I, Tran S, Quek SX, Khine HHTW, Itokawa N, Atsukawa M, Uojima H, Watanabe T, Takahashi H, Inoue K, Maeda M, Hoang JK, Trinh L, Barnett S, Cheung R, Lim SG, Trinh HN, Chuang WL, Tanaka Y, Toyoda H, Yu ML, Nguyen MH.

Dried blood spot‐based host genome analysis technique　targeting pathological associations with hepatitis B:
Development and clinical application in the Cambodian
population

Hepatol Res　53/P.1147-1155/2023

Hiroko Setoyama1,2 | Nao Nishida3 | Shintaro Nagashima4 | Ko Ko4 | Taiji Yamazoe1 | Yasuhito Tanaka2 | Masashi Mizokami3 | Junko Tanaka4 | Tatsuya Kanto1